Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.7850
+0.1059 (15.59%)
At close: Oct 9, 2025, 4:00 PM EDT
0.7080
-0.0770 (-9.81%)
Pre-market: Oct 10, 2025, 5:41 AM EDT
RVPH Market Cap
RVPH has a market cap or net worth of $75.62 million as of October 10, 2025. Its market cap has increased by 84.29% in one year.
Market Cap
75.62M
Enterprise Value
65.37M
1-Year Change
84.29%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since October 18, 2018, RVPH's market cap has increased from $25.21M to $75.62M, an increase of 199.98%. That is a compound annual growth rate of 17.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 65.42M | -22.40% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | 80.73M | 195.66% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 763.39B |
| Johnson & Johnson | 454.62B |
| AbbVie | 407.21B |
| UnitedHealth Group | 337.38B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.71B |